ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 19 filers reported holding ADMA BIOLOGICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $446,000,000 | +57.6% | 75,000 | +114.3% | 0.01% | +100.0% |
| Q1 2016 | $283,000,000 | -4.1% | 35,000 | -3.8% | 0.01% | 0.0% |
| Q4 2015 | $295,000,000 | -3.0% | 36,400 | 0.0% | 0.01% | -16.7% |
| Q3 2015 | $304,000,000 | -9.8% | 36,400 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $337,000,000 | -16.2% | 36,400 | -11.2% | 0.01% | -33.3% |
| Q1 2015 | $402,000,000 | – | 41,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |